Meyka Pro banner
NewGenIvf Group Limited

NewGenIvf Group Limited (NASDAQ: NIVFW) Stock Competitors & Peer Comparison

See NIVFW's competitors and their performance on the NASDAQ and across the wider stock market.

NIVFWNASDAQ
HealthcareMedical - Care Facilities
$0.02
$0.00(0.00%)
U.S. Market opens in 11h 2m

Peer Comparison Table: Medical - Care Facilities Industry

Detailed financial metrics including price, market cap, P/E ratio, and more for NIVFW and its NASDAQ peers.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
NIVFW$0.02-37.14%50K-0.01-$1.51N/A
HCA$382.19+1.51%84.8B13.20$28.96+0.78%
THC$233.20+17.17%20.1B13.53$17.24N/A
DVA$235.44+0.50%15.1B20.06$11.73N/A
SOLV$78.01+1.00%13.5B12.50$6.24N/A
FMS$24.59+0.61%13.2B9.76$2.52+3.52%
EHC$112.89+1.65%11.2B19.83$5.69+0.67%
ENSG$172.99+3.27%10.1B25.07$6.90+0.15%
UHS$155.75+2.96%9.8B6.91$22.54+0.51%
OSH$39.00+0.08%9.5B-17.65-$2.21N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

HCA Healthcare, Inc. (NYSE: HCA)

NIVFW vs HCA Comparison July 2026

NewGenIvf Group Limited (NASDAQ: NIVFW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NIVFW stands at 50K. In comparison, HCA has a market cap of 84.8B. Regarding current trading prices, NIVFW is priced at $0.02 on the NASDAQ, while HCA trades at $382.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NIVFW currently has a P/E ratio of -0.01, whereas HCA's P/E ratio is 13.20. In terms of profitability, NIVFW's ROE is +0.33%, compared to HCA's ROE of -1.54%. Regarding short-term risk, NIVFW is more volatile compared to HCA. This indicates higher risk in terms of short-term price fluctuations for NIVFW.Check HCA's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions